Skip to content

MOBILE Trial. Mechanical and Oral Antibiotic Bowel Preparation Versus no Bowel preparatIon for eLEctive Colectomy - a Multicenter, Prospective, Randomized, Controlled Trial.

MOBILE Trial. Mechanical and Oral Antibiotic Bowel Preparation Versus no Bowel preparatIon for eLEctive Colectomy - a Multicenter, Prospective, Randomized, Controlled Trial.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02652637
Enrollment
417
Registered
2016-01-12
Start date
2016-03-31
Completion date
2023-08-31
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Surgery

Brief summary

Enchanced recovery after surgery (ERAS) protocols aim to provide safer and quicker recovery postoperatively. One of the elements in ERAS protocols is that bowel is not prepared before colorectal surgery. However, several recent retrospective register studies have suggested that mechanical bowel preparation combined to oral antibiotics before colectomy reduces complications compared to no preparation at all. This trial compares these two strategies to find out whether complications can indeed be reduced by mechanically preparing the bowel with oral antibiotics.

Interventions

DRUGneomycin, metronidazole, polyethylene glycol (PEG)

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing colon resection

Exclusion criteria

* Emergency surgery needed * Bowel obstruction * Colonoscopy scheduled to be undertaken peroperatively * Other reason indicating mechanical preparation or contradicting it * Allergy to used drugs (PEG, neomycin, metronidazole)

Design outcomes

Primary

MeasureTime frame
Surgical site infection (CDC criteria)30 days from operation

Secondary

MeasureTime frame
Patients receiving adjuvant therapy divided by patients needing adjuvant therapy6 months from operation
Anastomotic dehiscence30 days from operation
Readmissions30 days from operation
Length of hospital stayDuring hospital stay, anticipated 2-30 days
Mortality30- and 90-days from operation
Comprehensive Complication Index30 days from operation
Adverse effects of antibiotics (diarrhea, clostridium)30 days from operation
Reoperations30 days from operation

Other

MeasureTime frame
5-year disease specific survival5 years from operation
5-year recurrence free survival5 years from operation
5-year overall survival5 years from operation

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026